Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis

  • Zhang, Xian (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Guo, Qinggong (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Chen, Jingtao (Department of Orthopaedics, the First Hospital Affiliated of Henan University) ;
  • Chen, Zhaohui (Department of Orthopaedics, the First Hospital Affiliated of Henan University)
  • Received : 2015.02.10
  • Accepted : 2015.04.23
  • Published : 2015.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Quercetin can suppress osteosarcoma cell growth and metastasis. However, other effects of quercetin on osteosarcoma remain largely unknown. This research aims to evaluate the effects of quercetin in combination with cisplatin as treatment for osteosarcoma and investigate its regulatory mechanism. Cell viability and apoptosis in 143B cell line were determined after treatment with quercetin and/or cisplatin. RT-PCR and Western blot analysis were performed to determine the RNA or protein expression levels. Moreover, transwell assay was used to evaluate metastasis. Furthermore, rescue experiments were performed to investigate the potential regulatory mechanism of the treatment. Results showed that quercetin with concentration that was equal to or greater than $10{\mu}M$ inhibited 143B proliferation, while $5{\mu}M$ quercetin enhanced the cisplatin sensitivity of 143B cells. Expression of miR-217 was upregulated after quercetin and/or cisplatin treatment, while its target KRAS was downregulated both at mRNA and protein levels. MiR-217 knockdown led to the loss of enhanced cisplatin sensitivity while miR-217 overexpression showed the opposite effects, indicating that quercetin regulated cisplatin sensitivity by modulating the miR-217-KRAS axis. In conclusion, $5{\mu}M$ quercetin enhanced the cisplatin sensitivity by modulating the miR-217-KRAS axis. This finding suggests that quercetin may be administered with cisplatin to improve the treatment for osteosarcoma.

Keywords

References

  1. Berndt, K., Campanile, C., Muff, R., Strehler, E., Born, W., and Fuchs, B. (2013). Evaluation of quercetin as a potential drug in osteosarcoma treatment. Anticancer Res. 33, 1297-1306.
  2. Bielack, S.S., Carrle, D., Hardes, J., Schuck, A., and Paulussen, M. (2008). Bone tumors in adolescents and young adults. Curr. Treat Options Oncol. 9, 67-80. https://doi.org/10.1007/s11864-008-0057-1
  3. Chou, A.J., Gupta, R., Bell, M.D., Riewe, K.O., Meyers, P.A., and Gorlick, R. (2013). Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatr. Blood Cancer 60, 580-586. https://doi.org/10.1002/pbc.24438
  4. Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., and Kroemer, G. (2012). Molecular mechanisms of cisplatin resistance. Oncogene 31, 1869-1883. https://doi.org/10.1038/onc.2011.384
  5. Guo, J.H., Feng, Z.J., Huang, Z., Wang, H.Y., and Lu, W.J. (2014). MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer. Mol. Cells 37, 664-671. https://doi.org/10.14348/molcells.2014.0121
  6. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009). TGFbeta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11, 881-U263. https://doi.org/10.1038/ncb1897
  7. Kim, J.Y., Kim, E.H., Park, S.S., Lim, J.H., Kwon, T.K., and Choi, K.S. (2008). Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 upregulation and proteasome-mediated c-FLIPS down-regulation. J. Cell Biochem. 105, 1386-1398. https://doi.org/10.1002/jcb.21958
  8. Li, N., Sun, C., Zhou, B., Xing, H., Ma, D., Chen, G., and Weng, D. (2014). Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer. PLoS One 9, e100314. https://doi.org/10.1371/journal.pone.0100314
  9. Liang, W., Li, X., Li, C., Liao, L., Gao, B., Gan, H., Yang, Z., and Chen, X. (2011). Quercetin-mediated apoptosis via activation of the mitochondrial-dependent pathway in MG-63 osteosarcoma cells. Mol. Med. Rep. 4, 1017-1023.
  10. Martinez-Velez, N., Xipell, E., Jauregui, P., Zalacain, M., Marrodan, L., Zandueta, C., Vera, B., Urquiza, L., Sierrasesumaga, L., Julian, M.S., et al. (2014). The oncolytic adenovirus Delta24-RGD in combination with cisplatin exerts a potent antiosteosarcoma activity. J. Bone Miner Res. 29, 2287-2296. https://doi.org/10.1002/jbmr.2253
  11. Orsolic, N., and Car, N. (2014). Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo. Tumour. Biol. 35, 6445-6454. https://doi.org/10.1007/s13277-014-1843-y
  12. Scambia, G., Ranelletti, F.O., Benedetti Panici, P., Bonanno, G., De Vincenzo, R., Piantelli, M., and Mancuso, S. (1990). Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer Drugs 1, 45-48. https://doi.org/10.1097/00001813-199010000-00008
  13. Shen, D.W., Pouliot, L.M., Hall, M.D., and Gottesman, M.M. (2012). Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol. Rev. 64, 706-721. https://doi.org/10.1124/pr.111.005637
  14. SS, B. (2012). A review of quercetin: Antioxidant and anticancer properties. World J. Pharm. Pharm. Sci. 1, 146-160.
  15. Suh, D.K., Lee, E.J., Kim, H.C., and Kim, J.H. (2010). Induction of G(1)/S phase arrest and apoptosis by quercetin in human osteosarcoma cells. Arch. Pharm. Res. 33, 781-785. https://doi.org/10.1007/s12272-010-0519-4
  16. Wang, P., Vadgama, J.V., Said, J.W., Magyar, C.E., Doan, N., Heber, D., and Henning, S.M. (2014). Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J. Nutr. Biochem. 25, 73-80. https://doi.org/10.1016/j.jnutbio.2013.09.005
  17. Wu, J., Liao, Q., He, H., Zhong, D., and Yin, K. (2014). TWIST interacts with beta-catenin signaling on osteosarcoma cell survival against cisplatin. Mol. Carcinog. 53, 440-446. https://doi.org/10.1002/mc.21991
  18. Xie, X.B., Yin, J.Q., Jia, Q., Wang, J., Zou, C.Y., Brewer, K.J., Colombo, C., Wang, Y.F., Huang, G., and Shen, J.N. (2011). Quercetin induces apoptosis in the methotrexate-resistant osteosarcoma cell line U2-OS/MTX300 via mitochondrial dysfunction and dephosphorylation of Akt. Oncol. Rep. 26, 687-693.
  19. Yi, L., Zongyuan, Y., Cheng, G., Lingyun, Z., Guilian, Y., and Wei, G. (2014). Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci. 105, 520-527. https://doi.org/10.1111/cas.12395
  20. Zhao, W.G., Yu, S.N., Lu, Z.H., Ma, Y.H., Gu, Y.M., and Chen, J. (2010). The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis 31, 1726-1733. https://doi.org/10.1093/carcin/bgq160
  21. Zhao, G.Y., Cai, C.K., Yang, T.T., Qiu, X.C., Liao, B., Li, W., Ji, Z.W., Zhao, J., Zhao, H.E., Guo, M.J., et al. (2013). MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8, e53906. https://doi.org/10.1371/journal.pone.0053906

Cited by

  1. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways vol.1864, pp.10, 2017, https://doi.org/10.1016/j.bbamcr.2017.06.017
  2. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy vol.39, pp.9, 2017, https://doi.org/10.1177/1010428317705762
  3. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor vol.17, pp.20, 2016, https://doi.org/10.1002/cbic.201600337
  4. Activation and conformational dynamics of a class B G-protein-coupled glucagon receptor vol.18, pp.18, 2016, https://doi.org/10.1039/C6CP00798H
  5. Molecular mechanisms of action of quercetin in cancer: recent advances vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5184-x
  6. MicroRNAs and Potential Targets in Osteosarcoma: Review vol.3, 2015, https://doi.org/10.3389/fped.2015.00069
  7. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling vol.12, pp.5, 2016, https://doi.org/10.1039/C6MB00031B
  8. Phase-plate cryo-EM structure of a class B GPCR–G-protein complex vol.546, pp.7656, 2017, https://doi.org/10.1038/nature22327
  9. Flavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-11391-x
  10. Formyl peptide receptor polymorphisms: 27 most possible ways for phagocyte dysfunction vol.82, pp.4, 2017, https://doi.org/10.1134/S0006297917040034
  11. Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges vol.40-41, 2016, https://doi.org/10.1016/j.semcancer.2016.04.002
  12. Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma vol.94, 2017, https://doi.org/10.1016/j.biopha.2017.07.075
  13. Structure and dynamics of GPCR signaling complexes vol.25, pp.1, 2018, https://doi.org/10.1038/s41594-017-0011-7
  14. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-018-07598-9
  15. Quercetin-mediated regulation of signal transduction cascades and microRNAs: Natural weapon against cancer vol.119, pp.12, 2018, https://doi.org/10.1002/jcb.27488
  16. PAC1 Receptors: Shapeshifters in Motion pp.1559-1166, 2018, https://doi.org/10.1007/s12031-018-1132-0
  17. Anticancer potential of quercetin: A comprehensive review pp.0951418X, 2018, https://doi.org/10.1002/ptr.6155
  18. Myricetin treatment induces apoptosis in canine osteosarcoma cells by inducing DNA fragmentation, disrupting redox homeostasis, and mediating loss of mitochondrial membrane potential vol.233, pp.9, 2018, https://doi.org/10.1002/jcp.26598
  19. Disturbance in biosynthesis of arachidonic acid impairs the sexual development of the onion blight pathogen Stemphylium eturmiunum pp.1432-0983, 2019, https://doi.org/10.1007/s00294-019-00930-w
  20. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies pp.1582-4934, 2019, https://doi.org/10.1111/jcmm.14064
  21. Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression vol.18, pp.2, 2015, https://doi.org/10.2174/1389202917666160803165229
  22. Noncoding RNA in drug resistant sarcoma vol.8, pp.40, 2015, https://doi.org/10.18632/oncotarget.19029
  23. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y 1 Receptor vol.7, pp.None, 2017, https://doi.org/10.1038/s41598-017-14268-1
  24. Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule vol.4, pp.None, 2018, https://doi.org/10.1038/s41420-018-0103-0
  25. GPCR structure and function relationship: identification of a biased apelin receptor mutant vol.475, pp.23, 2015, https://doi.org/10.1042/bcj20180740
  26. Endogenous and Exogenous Modulation of Nrf2 Mediated Oxidative Stress Response in Bovine Granulosa Cells: Potential Implication for Ovarian Function vol.20, pp.7, 2015, https://doi.org/10.3390/ijms20071635
  27. Controlling metastatic cancer: the role of phytochemicals in cell signaling vol.145, pp.5, 2015, https://doi.org/10.1007/s00432-019-02892-5
  28. Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential vol.9, pp.5, 2015, https://doi.org/10.3390/biom9050174
  29. Quercetin ameliorates lipopolysaccharide-caused inflammatory damage via down-regulation of miR-221 in WI-38 cells vol.108, pp.None, 2019, https://doi.org/10.1016/j.yexmp.2019.03.002
  30. The effect of quercetin on microRNA expression: A critical review vol.163, pp.2, 2015, https://doi.org/10.5507/bp.2019.030
  31. miR-548d-3p inhibits osteosarcoma by downregulating KRAS vol.11, pp.14, 2015, https://doi.org/10.18632/aging.102097
  32. Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice vol.62, pp.4, 2015, https://doi.org/10.5468/ogs.2019.62.4.242
  33. Effects of quercetin on microRNAs: A mechanistic review vol.120, pp.8, 2015, https://doi.org/10.1002/jcb.28663
  34. Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1 vol.20, pp.17, 2015, https://doi.org/10.3390/ijms20174293
  35. Quercetin analogs with high fetal hemoglobin-inducing activity vol.28, pp.10, 2015, https://doi.org/10.1007/s00044-019-02412-7
  36. miR-193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma vol.44, pp.1, 2015, https://doi.org/10.3892/or.2020.7601
  37. The role of microRNA in cisplatin resistance or sensitivity vol.24, pp.9, 2020, https://doi.org/10.1080/14728222.2020.1785431
  38. G-Protein coupled receptors: structure and function in drug discovery vol.10, pp.60, 2015, https://doi.org/10.1039/d0ra08003a
  39. Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives vol.10, pp.11, 2015, https://doi.org/10.3390/biom10111535
  40. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells vol.22, pp.2, 2015, https://doi.org/10.3390/ijms22020537
  41. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma vol.20, pp.None, 2015, https://doi.org/10.1177/15330338211034262
  42. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways vol.26, pp.5, 2015, https://doi.org/10.3390/molecules26051315
  43. Targeting epigenetics in cancer: therapeutic potential of flavonoids vol.61, pp.10, 2015, https://doi.org/10.1080/10408398.2020.1763910
  44. Possible connection between diet and microRNA in cancer scenario vol.73, pp.None, 2015, https://doi.org/10.1016/j.semcancer.2020.11.014
  45. Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms vol.144, pp.None, 2015, https://doi.org/10.1016/j.biopha.2021.112257
  46. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors vol.118, pp.51, 2015, https://doi.org/10.1073/pnas.2113373118